SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-087222
Filing Date
2022-08-08
Accepted
2022-08-08 16:06:51
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cldx-20220630x10q.htm   iXBRL 10-Q 1293163
2 EXHIBIT 10.3 cldx-20220630xex10d3.htm EX-10.3 25542
3 EXHIBIT 31.1 cldx-20220630xex31d1.htm EX-31.1 11574
4 EXHIBIT 31.2 cldx-20220630xex31d2.htm EX-31.2 11562
5 EXHIBIT 32.1 cldx-20220630xex32d1.htm EX-32.1 7338
  Complete submission text file 0001104659-22-087222.txt   5816663

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cldx-20220630.xsd EX-101.SCH 30993
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20220630_cal.xml EX-101.CAL 43958
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20220630_def.xml EX-101.DEF 139899
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20220630_lab.xml EX-101.LAB 329279
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20220630_pre.xml EX-101.PRE 241399
56 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20220630x10q_htm.xml XML 1226921
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 221144349
SIC: 2835 In Vitro & In Vivo Diagnostic Substances